Marrow B-cell precursors are increased in lymphomas or systemic diseases associated with B-cell dysfunction

Area of Science:

• Hematology
• Immunology
• Oncology

Background:

• Marrow regeneration involves increased immature B cells, including CD10+ cells.
• A similar phenotype is observed in pediatric cytopenias.
• This study investigates this phenotype in adults failing chemotherapy.

Purpose of the Study:

• To characterize the phenotype of increased CD10+ cells in adult bone marrows.
• To correlate this finding with underlying systemic illnesses.
• To determine if this phenotype indicates B-cell neoplasia.

Main Methods:

• Flow cytometry and multiparameter analysis of bone marrow cells.
• Phenotypic analysis of CD10+, CD19+, CD20, and TdT expression.
• Examination of bone marrow core biopsies.
• Clinical correlation with patient diagnoses.

Main Results:

• 21 adult patients showed increased CD10+ cells (10-76% of mononuclear cells) post-chemotherapy.
• These cells displayed a distinct phenotype: CD19+, surface immunoglobulin-negative, variably CD20+, and sometimes TdT+.
• Patients had systemic illnesses including lymphoma (n=13), autoimmune disease (n=7), and AIDS (n=1).
• Bone marrow biopsies showed lymphocyte proliferation, but no B-cell clonal excess was detected.

Conclusions:

• The CD10+ cell phenotype suggests nonspecific stimulation of B-cell precursors and systemic B-cell activation.
• This phenotype can occur in immunologic or neoplastic disorders, including lymphomas and autoimmune diseases.
• The presence of this phenotype alone does not confirm bone marrow involvement by B-cell neoplasia.